» Articles » PMID: 38946910

Protective Effects of Subsp. HFY14 Supplementation on the Brain, Intestines, and Motor Function of Antibiotic-treated Mice

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2024 Jul 1
PMID 38946910
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: This study aimed to explore the anti-oxidative and anti-inflammatory properties of . HFY14 (LLSLHFY14) and investigate its effects on the intestinal barrier, cranial nerve, and motor function in mice treated with antibiotics.

Methods: Mice were administered an antibiotic mixture (neomycin 5 mg/mL, vancomycin 25 mg/mL, amphotericin B 0.1 mg/mL, ampicillin 10 mg/mL, metronidazole file 5 mg/mL, and lipopolysaccharide 1.5 μg/mL) intraperitoneally, and oxidative stress and inflammatory markers in the serum and brain tissues, and liver index were measured. H&E staining was performed to detect pathological alterations in brain tissues. The expression of intestinal-barrier-related genes and that of genes involved in inflammatory pathways in the brain were detected using polymerase chain reaction (PCR).

Results: LLSLHFY14 administration extended the weight-loaded swimming and running times of mice and decreased the liver index. Moreover, the levels of malondialdehyde (MDA), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α) in the serum and brain tissue were reduced, whereas those of superoxide dismutase (SOD), glutathione (GSH), and interleukin-10 (IL-10) were elevated. Elevated brain expression of the protein kinase B ()/cAMP-response element binding protein ()/brain-derived neurotrophic factor ()/extracellular signal-regulated kinase 1 () pathway, decreased brain expression of the gene, and elevated cecum expression of , and genes were noted. LLSLHFY14 supplementation significantly increased expression but decreased expression, thus increasing the ratio.

Discussion: Overall, LLSLHFY14 supplementation ameliorated antibiotic-induced oxidative stress and inflammation in the mouse central nervous system, intestinal barrier dysfunction, and increased motor function, thus confirming its potential application as probiotics.

References
1.
Tian S, Guo R, Wei S, Kong Y, Wei X, Wang W . Curcumin protects against the intestinal ischemia-reperfusion injury: involvement of the tight junction protein ZO-1 and TNF-α related mechanism. Korean J Physiol Pharmacol. 2016; 20(2):147-52. PMC: 4770104. DOI: 10.4196/kjpp.2016.20.2.147. View

2.
Hu Y, Huang X, Zong X, Bi Z, Cheng Y, Xiao X . Chicory fibre improves reproductive performance of pregnant rats involving in altering intestinal microbiota composition. J Appl Microbiol. 2020; 129(6):1693-1705. DOI: 10.1111/jam.14679. View

3.
Zhu X, Han Y, Du J, Liu R, Jin K, Yi W . Microbiota-gut-brain axis and the central nervous system. Oncotarget. 2017; 8(32):53829-53838. PMC: 5581153. DOI: 10.18632/oncotarget.17754. View

4.
Desbonnet L, Clarke G, Traplin A, OSullivan O, Crispie F, Moloney R . Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav Immun. 2015; 48:165-73. DOI: 10.1016/j.bbi.2015.04.004. View

5.
Guo X, Jiang Q, Tuccitto A, Chan D, Alqawlaq S, Won G . The AMPK-PGC-1α signaling axis regulates the astrocyte glutathione system to protect against oxidative and metabolic injury. Neurobiol Dis. 2018; 113:59-69. DOI: 10.1016/j.nbd.2018.02.004. View